CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising demand for biopharmaceuticals
4.1.2. Increasing advantages of single-use aseptic sampling systems in improving the
efficiency of the process as well as reducing the product risk.
4.1.3. Fast implementation and decreased risk of product cross-contamination
4.2. Market Restraints & Challenges
4.2.1. Slow adoption of advanced technologies in biopharmaceutical manufacturing
4.2.2. Issues regarding and leachables into the solvent
4.2.3. Strict government regulations for ensuring drug safety
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Patent expiry of major drugs
CHAPTER 5. GLOBAL ASEPTIC SAMPLING MARKET – BY TYPE
5.1. Manual Aseptic Sampling
5.1.1. Bags
5.1.2. Bottles
5.1.3. Syringes
5.1.4. Accessories
5.2. Automated Aseptic Sampling
CHAPTER 6. GLOBAL ASEPTIC SAMPLING MARKET – BY TECHNIQUE
6.1. Off-Line Sampling
6.2. At-Line Sampling
6.3. On-Line Sampling
CHAPTER 7. GLOBAL ASEPTIC SAMPLING MARKET – BY APPLICATION
7.1. Upstream Processes
7.2. Downstream Processes
CHAPTER 8. GLOBAL ASEPTIC SAMPLING MARKET – BY END USER
8.1. Academic & Research Institutes
8.2. Pharmaceutical & Biotechnology Companies
8.3. CROs and CMOs
8.4. Others
CHAPTER 9. GLOBAL ASEPTIC SAMPLING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ASEPTIC SAMPLING MARKET - COMPANY PROFILES
10.1. Merck KGaA
10.2. Danaher Corporation
10.3. Thermo Fisher Scientific Inc.
10.4. Sartorius Stedim Biotech SA
10.5. Saint Gobain S.A.
10.6. GEA Group AG
10.7. Keofitt, Gemü Group
10.8. W. L. Gore & Associates, Inc.
10.9. Flownamics Analytical Instruments
10.10. Lonza Group
10.11. Trace Analytics and Bürkle GmbH
10.12. Keofitt
10.13. Qualitru Sampling Systems
CHAPTER 11. GLOBAL ASEPTIC SAMPLING MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
